期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

口腔颌面头颈鳞癌相关基因TGM3，OPN，MAL和LAGY的功能研究进展 被引量：1

Advancement in the Functional Study of Oral and Maxillofacial Head and Neck Squamous Cell Carcinoma Associated Genes TGM3,OPN,MAL and LAGY
下载PDF
导出
摘要 在世界范围内。人口腔颌面头颈癌的发病率占全身癌的第六位。其中至少80％是鳞状细胞癌，在一些发展中国家．口腔颌面头颈鳞癌构成比占所有恶性肿瘤的50％。口腔颌面头颈鳞癌的治疗经过以手术、放疗、化疗为主要手段的综合序列治疗，患者的长期生存率虽然得到了一定的提高。5年生存率达到了65％．但是该类患者的长期生存率和生存质量仍不理想．特别是晚期鳞癌患者的预后较差。
作者 曹巍 陈万涛 张萍
机构地区 上海交通大学医学院 上海交通大学医学院附属第九人民医院口腔颌面外科
出处 《口腔颌面外科杂志》 CAS 2007年第4期357-361,共5页 Journal of Oral and Maxillofacial Surgery
基金 上海市重点学科(优势学科)建设项目(Y0203) 国家自然科学基金重点项目(30330580)
关键词 口腔 鳞状细胞癌 转谷氨酰胺酶3基因 骨桥蛋白基因 T淋巴细胞成熟相关基因 肺癌相关基因 oral cavity squamous cell carcinoma transglutaminase-3（TGM3） osteopontin（OPN） myelin and lymphocyte （MAL） lung cancer-associated gene Y（LAGY）
分类号 R739.8 [医药卫生—肿瘤] Q343.17 [生物学—遗传学]
  • 相关文献

参考文献41

  • 1Hoffman HT, Karnell LH, Funk GF, et al. The national cancer data base report on cancer of the head and neck [J]. Arch Otolaryngol Head Neck Surg, 1998,124(9):951-962.
  • 2Califano J, van der Riet P, Westra W, et al. Genetic progression model for head and neck cancer:implications for field cancerization[J]. Cancer Res,1996,56(11):2488-2492.
  • 3Kuriakose MA, Chen WT, He ZM, et al. Selection and validation of differentially expressed genes in head and neck cancer[J]. Cell Mol Life Sci, 2004,61(11):1372-1383.
  • 4Grenard P, Bates MK, Aeschlimann D. Evolution of transglutaminase genes: identification of a transglutaminase gene cluster on human chromosome 15q15. Structure of the gene encoding transglutaminase X and a novel gene family member, transglutaminase Z[J].J Biol Chem,2001, 276(35):33066-33078.
  • 5Wang M, Kim IG, Steinert PM, et al. Assignment of the human transglutaminase 2 (TGM2) and transglutaminase 3 (TGM3) genes to chromosome 20q11.2[J].Genomics,1994, 23(3):721-722.
  • 6Kim IG, Lee SC, Lee JH, et al. Structure and organization of the human transglutaminase 3 gene: evolutionary relationship to the transglutaminase family[J].J Invest Dermatol,1994,103(2): 137-142.
  • 7Ahvazi B, Kim HC, Kee S-H, et al. Three-dimentional structure of the human transglutaminase 3 enzyme: binding of calcium ions changes structure for aetivation[J].EMBO,2002,21 (9):2055-2067.
  • 8Kim HC, Nemes Z, Idler WW, et al. Crystallization and preliminary X-Ray analysis of human transglutaminase 3 from zymogen to active form[J].J Struct Biol,2001, 135(1): 73-77.
  • 9贺光,赵震,富伟能,孙兴和,徐振明,孙开来.喉癌中转谷氨酰胺酶3基因杂合性丢失和表达研究[J].中华医学遗传学杂志,2002,19(2):120-123. 被引量：8
  • 10Gonzalez HE, Gujrati M, Frederick M, et al. Identification of 9 genes differentially expressed in head and neck squamous cell carcinoma[J].Arch Otolaryngol Head Neck Surg, 2003,129(7):754-759.

二级参考文献21

  • 1郭星,程美华.辽宁省喉癌病因学病例对照调查分析[J].中华耳鼻咽喉科杂志,1993,28(4):219-221. 被引量：4
  • 2许智雄 王明荣 等.人食管癌表达下调基因的分离和表达分析.中国科协第三届青年学术年会论文集（生命科学与生物技术）[M].北京:中国科学技术出版社,1998.226-228.
  • 3贺光 富伟能 孙开来 等.应用cDNA—RDA方法筛查喉癌新的相关基因[J].中国医学生物学研究,2001,3:283-286.
  • 4Sambrook J, Fritsch EF, Maniatis T. Translated by Jin DY, Li MF,Hou YD, et al. Molecular cloning-a laboratory manual. 2nd ed. Beijing: Science Press. 1998.362-371.[Sambrook J, Fritsch EF, Maniatis T,著.金冬雁,黎孟枫,侯云德等译. 分子克隆实验指南. 第2版,北京:科学出版社,1998.362-371.]
  • 5Fracchiolla NS, Pignataro L, Capaccio P,et al. Multiple genetic lesions in laryngeal squamous cell carcinomas. Cancer, 1995,75∶1292-1301.
  • 6Jares P, Fernandez PL, Campo E, et al. PRAD-1/cyclin D1 gene amplification correlates with messenger RNA overexpression and tumor progression in human laryngeal carcinomas. Cancer Res, 1994,54∶4813-4817.
  • 7Somers KD, Cartwright SL, Schechter GL, et al. Amplification of the int-2 gene in human head and neck squamous cell carcinomas. Oncogene, 1990,5∶915-920.
  • 8Scholnick SB, Sun PC, Shaw ME, et al. Frequent loss of heterozygosity for Rb, TP53, and chromosome arm 3p, but not NME1 in squamous cell carcinomas of the supraglottic larynx. Cancer, 1994,73∶2472-2480.
  • 9Cordella-Miele E, Miele L, Mukherjee AB. A novel transglutaminase-mediated post-translational modification of phospholipase A2 dramatically increases its catalytic activity. J Biol Chem, 1990,265∶17180-17188.
  • 10Nadeau OW, Carlson GM. Zero length conformation-dependent cross-linking of phosphorylase kinase subunits by transgluta-minase. J Biol Chem, 1994,269∶29670-29676.

共引文献15

同被引文献19

  • 1Scatena M, Liaw L, Giachelli CM. Osteopontin: a multifunctional molecule regulating chronic inflammation and vascular disease[J]. Arterioscler Thromb Vasc Biol, 2007, 27(11):2302-2309.
  • 2Agnhoh J, Kelsen J, Schack L, et al. Osteopontin, a protein with cytokine-like properties, is associated with inflammation in Crohn's disease[J]. Scand J Immunol, 2007, 65(5):453-460.
  • 3Cao ZG, Dai JX, Fan KX, et al. A novel functional motif of osteopontin for human lymphocyte migration and survival[J]. Molecular Immunology, 2008, 45(14):3683-3692.
  • 4Denhardt DT,Guo X. Osteopontin: a protein with diverse functions [J]. FASEB J,19937(15):1475-1482.
  • 5Wai PY, Kuo PC. The role of osteopontin in tumor metastasis[J]. J Surg Res, 2004, 121(2): 228-241.
  • 6Donati V, Boldrini L, Dell Omodarme M, et al. Osteopontin expression and prognostic significan in Non-small lung cancer[J]. Clin Cancer Res, 2005, 11(18):6459-6465.
  • 7Wu IC, Wu MT, Chou SH, et al. Osteopontin expression in squamous cell cancer of the esophagus [J]. World J Surg, 2008, 32(9):1989-1995.
  • 8Zhao J, Dong L, Liu B, et al tin suppresses growth and Down-regulation of osteopon- metastasis of hepatocellular carcinoma via induction of apoptosis[J]. Gastroenterology, 2008,135(3):956-968.
  • 9Matsuzaki H, Shima K, Muramatsu T, et al. Osteopontin as biomarker in early invasion by squamous cell carcinoma in tongue[J]. J Oral Pathol Med, 2007, 36(1):30-34.
  • 10Rittling SR,Chambers AF.Role of osteopontin in tumour progression[J].Br J Cancer, 2004,90(10): 1877-1851.

引证文献1

二级引证文献2

口腔颌面外科杂志
2007年 第4期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部